Skip to content

Study on evidence-based optimization of TCM diagnosis and treatment scheme for coronary heart disease complicated with diabetes

Study on evidence-based optimization of TCM diagnosis and treatment scheme for coronary heart disease complicated with diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085954
Enrollment
Unknown
Registered
2024-06-21
Start date
2024-06-30
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease complicated with diabetes

Interventions

Inpatients with coronary heart disease complicated with diabetes in Liaoning Province treated with traditional Chinese medicine:None

Sponsors

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of both Chinese and Western medicine for coronary heart disease and diabetes; 2. Patients aged between 30 and 89 years old; 3. Standardized and comprehensive medical record data for diagnosis and treatment of traditional Chinese and Western medicine

Exclusion criteria

Exclusion criteria: 1. Patients with severe valvular heart disease (such as rheumatic heart disease), various types of cardiomyopathy (such as dilated cardiomyopathy, hypertrophic cardiomyopathy), malignant arrhythmias (such as permanent and persistent atrial fibrillation, third degree atrioventricular block, etc.), infectious endocarditis, congenital heart disease, and other serious heart disease other than coronary artery diseases; 2. Patients with acute complications of diabetes (such as hypertonic coma, diabetes ketoacidosis and diabetes acute infection), patients with diabetes-related cognitive dysfunction, patients with type I diabetes, and patients with special types of diabetes; 3. Patients with uncontrolled hypertension (Bp = 180/110mmHg); 4. Patients with severe pulmonary insufficiency with PaO2<60mmHg, patients with moderate and severe hepatic insufficiency with transaminase level exceeding 3 times the upper limit of normal value, and patients with moderate and severe renal insufficiency with eGFR < 30ml/min/1.73m2; 5. Patients with severe primary diseases in the endocrine and hematopoietic systems, newly diagnosed acute cerebrovascular diseases in the past three months, or diagnosed with severe rheumatic and immune system diseases; 6. Patients with mental illness; 7. Pregnant or lactating individuals; 8. Life expectancy<1 year; 9. Patients who have been hospitalized for less than 3 days; 10. Patients whose symptoms do not match clinical manifestations.

Design outcomes

Primary

MeasureTime frame
Symptoms of cardiothoracic discomfort;Symptoms of polydipsia, polyphagia, polyuria and weight loss;Symptoms related to body fluid metabolism;General symptom;Tongue picture;Pulse condition; Diagnosis of traditional Chinese medicine at admission;Western medicine diagnosis at admission;Diagnosis of traditional Chinese medicine at discharge; Western medicine diagnosis at discharge; Traditional Chinese medicine prescription;Treatment principle and treatment method; General treatment of Western medicine; Western medicine treatment;

Secondary

MeasureTime frame
Basic information;medical/case history;Vital signs;Laboratory examination; electrocardiogram (ECG);Cardiac ultrasound;Nursing based on differentiation; Health education information;

Countries

China

Contacts

Public ContactLIU Ning

The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

410845168@qq.com+86 188 4052 9158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026